Comparison of Molecular Signatures from Multiple Skin Diseases Identifies Mechanisms of Immunopathogenesis

The ability to obtain gene expression profiles from human disease specimens provides an opportunity to identify relevant gene pathways, but is limited by the absence of data sets spanning a broad range of conditions. Here, we analyzed publicly available microarray data from 16 diverse skin conditions in order to gain insight into disease pathogenesis. Unsupervised hierarchical clustering separated samples by disease and common cellular and molecular pathways. Disease specific signatures were leveraged to build a multi-disease classifier which predicted the diagnosis of publicly and prospectively collected expression profiles with 93% accuracy. In one sample, the molecular classifier differed from the initial clinical diagnosis and correctly predicted the eventual diagnosis as the clinical presentation evolved. Finally, integration of interferon (IFN) regulated gene programs with the skin database revealed a significant inverse correlation between IFN–β and IFN–γ programs across all conditions. Our study provides an integrative approach to the study of gene signatures from multiple skin conditions, elucidating mechanisms of disease pathogenesis. Additionally, these studies provide a framework for developing tools for personalized medicine towards the precise prediction, prevention, and treatment of disease on an individual level.

[1]  James McCluskey,et al.  Human leukocyte antigen-associated drug hypersensitivity. , 2013, Current opinion in immunology.

[2]  P. van Erp,et al.  Molecular diagnostics of psoriasis, atopic dermatitis, allergic contact dermatitis and irritant contact dermatitis , 2010, The British journal of dermatology.

[3]  R. Freire,et al.  Interferon-induced sarcoidosis , 2011, BMJ Case Reports.

[4]  Jun Yan,et al.  New insights of T cells in the pathogenesis of psoriasis , 2012, Cellular and Molecular Immunology.

[5]  Rafael A Irizarry,et al.  Frozen robust multiarray analysis (fRMA). , 2010, Biostatistics.

[6]  J. Ring,et al.  Mutual antagonism of T cells causing psoriasis and atopic eczema. , 2011, The New England journal of medicine.

[7]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[8]  Mayte Suárez-Fariñas,et al.  Expanding the Psoriasis Disease Profile: Interrogation of the Skin and Serum of Patients with Moderate-to-Severe Psoriasis , 2012, The Journal of investigative dermatology.

[9]  James T. Elder,et al.  Heterogeneity of Inflammatory and Cytokine Networks in Chronic Plaque Psoriasis , 2012, PloS one.

[10]  P. Brown,et al.  Interferon and Biologic Signatures in Dermatomyositis Skin: Specificity and Heterogeneity across Diseases , 2012, PloS one.

[11]  J. Krutmann,et al.  Lesional expression of interferon-gamma in atopic eczema. , 1994, Lancet.

[12]  Andrew Johnston,et al.  Transcriptome analysis of psoriasis in a large case-control sample: RNA-seq provides insights into disease mechanisms , 2014, The Journal of investigative dermatology.

[13]  W. Fujimoto,et al.  Differential Expression of Human Cornifin α and β in Squamous Differentiating Epithelial Tissues and Several Skin Lesions. , 1997 .

[14]  A. Irvine,et al.  Filaggrin in atopic dermatitis. , 2008, The Journal of allergy and clinical immunology.

[15]  Brad T. Sherman,et al.  Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.

[16]  Andrew Johnston,et al.  Dissecting the psoriasis transcriptome: inflammatory- and cytokine-driven gene expression in lesions from 163 patients , 2013, BMC Genomics.

[17]  R. Clark,et al.  IL-15 and dermal fibroblasts induce proliferation of natural regulatory T cells isolated from human skin. , 2007, Blood.

[18]  Leo Breiman,et al.  Random Forests , 2001, Machine Learning.

[19]  Andreas Rytz,et al.  The limit fold change model: A practical approach for selecting differentially expressed genes from microarray data , 2002, BMC Bioinformatics.

[20]  Yuan-Tsong Chen,et al.  Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis , 2008, Nature Medicine.

[21]  A. Bowcock,et al.  Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities. , 2011, The Journal of allergy and clinical immunology.

[22]  J. Krutmann,et al.  Lesional expression of interferon-γ in atopic eczema , 1994, The Lancet.

[23]  Q. Hamid,et al.  Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. , 1994, The Journal of clinical investigation.

[24]  Virginia Pascual,et al.  A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. , 2008, Immunity.

[25]  W. Fujimoto,et al.  Differential expression of human cornifin alpha and beta in squamous differentiating epithelial tissues and several skin lesions. , 1997, The Journal of investigative dermatology.

[26]  A. Nanda Concomitance of psoriasis and atopic dermatitis. , 1995, Dermatology.

[27]  Yihong Yao,et al.  Type I Interferon: Potential Therapeutic Target for Psoriasis? , 2008, PloS one.

[28]  T. Graeber,et al.  Type I Interferon Suppresses Type II Interferon–Triggered Human Anti-Mycobacterial Responses , 2013, Science.

[29]  A. Grassegger,et al.  Significance of the cytokine interferon gamma in clinical dermatology , 2004, Clinical and experimental dermatology.

[30]  A. Wahba-Yahav Disease concomitance in psoriasis. , 1996, Journal of the American Academy of Dermatology.

[31]  Alex E. Lash,et al.  Gene Expression Omnibus: NCBI gene expression and hybridization array data repository , 2002, Nucleic Acids Res..

[32]  Defining protective responses to pathogens: cytokine profiles in leprosy lesions. , 1991, Science.

[33]  Y. Tu,et al.  Quantitative noise analysis for gene expression microarray experiments , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[34]  M. Marques,et al.  Mycosis fungoides and Sézary syndrome: clinical, histopathological and immunohistochemical review and update , 2012, Anais brasileiros de dermatologia.

[35]  S. Skurkovich,et al.  Inhibition of IFN-gamma as a method of treatment of various autoimmune diseases, including skin diseases. , 2006, Ernst Schering Research Foundation workshop.

[36]  Martine Bagot,et al.  Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells. , 2004, The Journal of allergy and clinical immunology.

[37]  J. Krutmann,et al.  Analysis of the cytokine pattern expressed in situ in inhalant allergen patch test reactions of atopic dermatitis patients. , 1995, The Journal of investigative dermatology.

[38]  P. Brown,et al.  Dissecting Interferon-Induced Transcriptional Programs in Human Peripheral Blood Cells , 2010, PloS one.